CGEN, NHPR, LSCC, CRWE, ANAD - CRWEWallstreet.com Stock Report! February 25th 2011

The uninsured can't pay, health care providers change those costs to the people who ultimately can pay-those who have insurance policies.
By: Hanson
 
Feb. 25, 2011 - PRLog -- Compugen Ltd.  reported financial results for the fourth quarter and year-ending December 31, 2010. Dr. Anat Cohen-Dayag, president and CEO, stated, “Compugen’s long-term commitment to pioneering predictive drug discovery continues to provide the basis for the development of unique and powerful discovery capabilities in areas of high industry interest and unmet medical needs. For example, during 2010 we announced the development of three additional discovery platforms: the Protein Family Members Discovery Platform, the Protein-Protein Interaction Blockers Discovery Platform, and the Intracellular Drug Delivery Discovery Platform. In addition, during the past few months, field extension modules were added to our previously disclosed monoclonal antibody (mAb) target discovery capability.”

Compugen Ltd., an early stage drug and diagnostic discovery company, engages in the research, development, and commercialization of therapeutic peptides and proteins for cancer, cardiovascular, and immune-related diseases in the United States and Europe.





Today's uninsured spend more for care-and are getting less-than those with insurance. However when the uninsured can't pay, health care providers change those costs to the people who ultimately can pay-those who have insurance policies. That causes much higher monthly premiums for those who buy the insurance, male or female, on the market, as well as staff who get insurance to cover for themselves and their loved ones. The need for affordable healthcare alternatives has never been greater.

Read more at: http://crwewallstreet.com/?p=16067
End
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share